Skip to content

Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801.

Peter U Hámor, Jana Šírová, Tomáš Páleníček, Magdalena Zaniewska, Vĕra Bubeníková‐valešová, Marek Schwendt

Pharmacology, Biochemistry, and Behavior December 2018 DOI: 10.1016/j.pbb.2018.09.007 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical experimental study Peer reviewed
Population Adult male rats
Interventions Methamphetamine Phencyclidine MK-801
Dose Methamphetamine self-administration (6 h/day); PCP 5 mg/kg twice/day; MK-801 0.3 mg/kg twice/day
Duration 14 days of drug administration, with tissue collection 7 days after discontinuation
Topics Serotonin
Keywords 5-ht2a Heterocomplex Mk-801 Methamphetamine Phencyclidine Mglu2
Key findings Chronic methamphetamine, PCP, and MK-801 all increased the 5-HT2A/mGlu2 expression ratio in the rat medial prefrontal cortex, with region-specific increases in the perirhinal cortex (meth and PCP) and dorsal hippocampus (MK-801 only). Meth also increased Gαq and decreased Gαi in the medial prefrontal cortex. The authors propose that increased cortical 5-HT2A relative to mGlu2 availability and G-protein coupling may be a common neurobiological mechanism underlying psychosis and cognitive deficits in meth use disorder and schizophrenia.

Abstract

Chronic methamphetamine (meth) abuse often turns into a compulsive drug-taking disorder accompanied by persistent cognitive deficits and re-occurring psychosis. Possible common neurobiological substrates underlying meth-induced deficits and schizophrenia remain poorly understood. Serotonin 2A (5-HT2A) and metabotropic glutamate 2 (mGlu2) receptors co-regulate psychosis-like behaviors and cognitive function in animals. Therefore, in the present study we examined the effects of chronic exposure to three different drugs known to produce persistent deficits in sensorimotor gating and cognition [meth, phencyclidine (PCP) and MK-801] on the expression of 5-HT2A and mGlu2 within the rat medial prefrontal cortex (mPFC), dorsal hippocampus (dHPC) and perirhinal cortex (PRh). Adult male rats underwent 14 days of: (a) meth self-administration (6 h/day), (b) phencyclidine (PCP; 5 mg/kg, twice/day) administration, or (c) MK-801 (0.3 mg/kg, twice/day) administration. Seven days after the discontinuation of drug administration, tissues of interest were collected for protein expression analysis. We found that despite different pharmacological mechanism of action, chronic meth, PCP, and MK-801 similarly dysregulated 5-HT2A and mGlu2, as indicated by an increase in the 5-HT2A/mGlu2 expression ratio in the mPFC (all three tested drugs), PRh (meth and PCP), and dHPC (MK-801 only). Complementary changes in G-protein expression (increase in Gαq and decrease in Gαi) were also observed in the mPFC of meth animals. Finally, we found that 5-HT2A/mGlu2 cooperation can be mediated in part by the formation of the receptor heteromer in some, but not all cortical regions. In summary, these data suggest that a shift towards increased availability (and G-protein coupling) of cortical 5-HT2A vs. mGlu2 receptors may represent a common neurobiological mechanism underlying the emergence of psychosis and cognitive deficits observed in subjects with meth use disorder and schizophrenia.

Comparable studies

Other preclinical and animal studies on serotonin, most cited first.

Citations in the library

Explore topics